Nilogen Oncosystems

Nilogen Oncosystems is committed to improving the efficiency and reducing risks in the oncology drug development process by creating 3D models of patient tumor biology that are as accurate and information-rich as possible. We have developed the most clinically relevant models of patient tumor biology and integrated them with the latest analytical technologies, bioinformatics tools, and artificial intelligence algorithms to assist translational scientists in making better decisions about their candidate therapies. Through this service, we have helped companies identify therapeutic candidates with the highest likelihood of clinical success, increasing the chances of success and reducing overall development costs.